Application 209354
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DUOBRII | HALOBETASOL PROPIONATE; TAZAROTENE | LOTION;TOPICAL | 0.01%;0.045% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-0653 | Duobrii | halobetasol propionate and tazarotene | Bausch Health US, LLC | NDA | Current |
| 0187-0653 | Duobrii | halobetasol propionate and tazarotene | Bausch Health US, LLC | NDA | Current |
| 0187-0653 | Duobrii | halobetasol propionate and tazarotene | Bausch Health US, LLC | NDA | Current |
| 0187-0653 | Duobrii | halobetasol propionate and tazarotene | Valeant Pharmaceuticals North America LLC | NDA | Current |